Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The product is expected to start contributing meaningfully to the revenue from FY25
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
The product is being launched in August 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Subscribe To Our Newsletter & Stay Updated
